Silencing ZEB1 upregulates E-cadherin, suppresses the migration and invasion of ovarian cancer cells in vivo and in vitro, and increases the expression of miR-200c, leading to EMT inhibition (Chen et al., 2013[15]). Here, ZEB1 is linked to ovarian carcinoma.